News

In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P).

The Scottish Medicines Consortium (SMC) has announced that Saflutan (tafluprost) has been accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure (IOP) in open angle glaucoma and ocular hypertension

Performing surgery in unfamiliar surroundings.

Transconjunctival Muscle Suturing is a new technique that decreases the size of opening by approximately one third.

New model produces results comparable with current glaucoma assessment methods

A proprietary tonometer has been found to be compatible with the Goldmann tonometer in several clinical trials.

Diabetic macular oedema responds to treatment with ranibizumab according to the results of the RESOLVE study.

A doctor's perspective on what influences IOL lens design.

Several manufacturers are developing femtosecond laser technology as a tool for multiple applications in cataract surgery. Three surgeons, who presented at this year's ESCRS Congress look at its uses and results.

Data suggest endothelial stability with Descemet's stripping automated endothelial keratoplasty but is longer-term follow-up needed?

A superior refractive corneal correction can be achieved by the preservation of corneal tissue as well as optimization of ablation profiles that are better adapted to human sight.

A new Tecnis intraocular lens harnesses the ease of implantation of a one-piece implant design and combines it with a glistening-free hydrophobic acrylic material for another next generation IOL.

A comparison study of patients who underwent minimally invasive strabismus surgery (MISS) with a total dissection of the plicated part of the rectus muscle and those who had MISS where only a marginal dissection was performed.

Advanced Cell Technology has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic-stem-cell-derived retinal cells to treat patients with Stargardt?s Macular Dystrophy (SMD).

The ExciStar XS series from Coherent, Inc. represents a compact, economical excimer laser offering performance and lifetime characteristics.

A study into the process of retinal cell death could hold the key to stopping a variety of eye diseases that cause blindness, according to a report from a team of researchers from the Yale School of Medicine reported in the journal Investigative Ophthalmology & Visual Science.

Poor communication is leading to a high number of mistakes in ophthalmic surgeries, according to a study published in the November issue of Archives of Surgery.

NeoVista has announced that treatment for neovascular AMD using the company?s VIDON ANV Therapy System has begun in Europe. The new system replaces the current course of eye injections with a surgical vitrectomy and a single dose of beta radiation.

Oertli?s new surgical platform Faros, has received its CE mark after meeting EU consumer safety, health or environmental requirements. This important step for the platform keeps it on schedule for an expected March 2010 release.

The IOPtiMate laser-based system, from the Bio-Light Group, used for the non-invasive filtration treatment of glaucoma has received European Patent Office approval.

The NAVILAS laser system, as reported on in the OTE Digest back in May this year ( What is Retinal Navigation? ) has been given FDA approval.

Lumenis is to undertake a clinical study into the efficacy of selective retina therapy (SRT) in diabetic macular oedema (DME).

Ellex Medical Lasers Ltd. unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology.

Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation?s board of directors.

An accommodating lens has the potential to provide functional vision at all distances in a seamless continuum and overcome dysphotopsias.

One surgeon's preference for an ophthalmic viscosurgical device of 1.6% sodium hyaluronate was reinforced by a study that found it superior to another OVD during phaco and OVD removal

The fusion of imaging technology for today and tomorrow to assess your patients' retinal health

Professor Mats Lundstrom, chairman of EUREQUO, talks to OTE about the project and its dissemination in Europe.

Taking the first step towards analysing your career goals and the return on your investment.